性啪啪chinese东北女人,人人妻人人澡人人爽人人精品,色av综合网

Top 10 Best-Selling Drugs in Q1 2025 Market Trend Discover the top 10 best-selling drugs of Q1 2025. GLP-1 drugs dominate, with semaglutide and tirzepatide leading growth. Oncology and autoimmune treatments face challenges amid rising competition and patent expirations.
Merck KGaA Advances Lupus Drug Enpatoran to Phase 3 Merck Merck KGaA advances its lupus drug enpatoran into phase 3 after positive phase 2 results in cutaneous lupus, despite setbacks in systemic lupus cohorts. The drug shows strong efficacy and a favorable safety profile.
The Streptomycin Controversy: Waksman, Schatz, and the Battle for Recognition Merck Discover the dramatic true story behind streptomycin's discovery, the scientific rivalry between Waksman and Schatz, and the ethical debates over recognition, patents, and the Nobel Prize.
Merck's Q1 2025 Financial report Financial statements Merck's Q1 2025 earnings show a 2% decline in revenue, with strong growth in KEYTRUDA and animal health products. The company faces short-term challenges but continues to drive innovation in its R&D pipeline.
Top 10 Oncology Products by Global Sales in 2024 Oncology Explore the top 10 global oncology drugs of 2024 by sales. Discover leading therapies like Keytruda and Darzalex, modality trends, solid vs. blood tumor market insights, and the growing role of cell and gene therapies.
2024 Global Top 10 Pharmaceutical Companies Market Trend The 2024 global ranking of the top 10 pharmaceutical companies showcases the continued strength of industry leaders like Johnson & Johnson, Roche, and Merck. Pfizer, AstraZeneca, and Eli Lilly also maintain strong positions with impressive growth and strategic investments.
The Global Vaccine Market: How Pfizer, Merck, GSK & Sanofi Maintain Their Dominance Market Trend As the pandemic subsides, the industry is returning to pre-pandemic dynamics, with Pfizer strengthening its pneumonia vaccine leadership, Merck betting on HPV and RSV, GSK focusing on meningitis, and Sanofi expanding its RSV monoclonal antibody business.
Top 10 Pharmaceutical Giants' R&D Investments in 2024 Market Trend In 2024, pharmaceutical giants face a quiet battle over innovation and efficiency. From Merck’s 41% R&D drop to AbbVie’s bold growth, their strategies and investments reveal shifting power in the industry. A glimpse into the future of drug development.
Top 10 Global Pharmaceutical Giants in Oncology Business for 2024 Oncology Discover the top 10 pharmaceutical giants leading the oncology industry in 2024. From Merck's dominance with Keytruda to AstraZeneca's rise, these companies are making strides in cancer treatment, innovation, and growth.
Pharmaceutical Giants Ranking 2024 Market Trend Explore the top pharmaceutical giants of 2024, including Merck, Johnson & Johnson, and more. Learn about their revenue, profits, R&D investments, and market value in this detailed ranking report.

< Pre 123 Next >

Articles Archives

Hot Articles

All Categories

Agri & Industry Cosmetic Laboratory Pharmaceutical Food

永久免费毛片_亚洲成人看片_亚洲春色另类_亚洲综合免费视频_最新高清无码专区_午夜影院a